NBN and Mobius syndrome: These data, together with the fact that MBs were observed in NBS patients [151], and heterozygous germline or somatic mutations in NBS1, RAD50, and MRE11A were discovered in MB patients [152,153,154,155], suggest that MRN genes may work as haploinsufficient oncosuppressors in MB development.